NO963255L - Sykliske neurokinin-A antagonister - Google Patents

Sykliske neurokinin-A antagonister

Info

Publication number
NO963255L
NO963255L NO963255A NO963255A NO963255L NO 963255 L NO963255 L NO 963255L NO 963255 A NO963255 A NO 963255A NO 963255 A NO963255 A NO 963255A NO 963255 L NO963255 L NO 963255L
Authority
NO
Norway
Prior art keywords
indolylmethyl
hydroxybenzyl
antagonists
conh
benzyl
Prior art date
Application number
NO963255A
Other languages
English (en)
Norwegian (no)
Other versions
NO963255D0 (no
Inventor
Thomas Joseph Owen
Elizabeth Mary Kudlacz
Stephen Henderson Buck
Scott Lee Harbeson
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO963255D0 publication Critical patent/NO963255D0/no
Publication of NO963255L publication Critical patent/NO963255L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO963255A 1994-02-03 1996-08-02 Sykliske neurokinin-A antagonister NO963255L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/191,571 US5521156A (en) 1994-02-03 1994-02-03 Cyclic neurokinin A antagonists
PCT/US1995/000296 WO1995021187A1 (en) 1994-02-03 1995-01-10 Cyclic neurokinin a antagonists

Publications (2)

Publication Number Publication Date
NO963255D0 NO963255D0 (no) 1996-08-02
NO963255L true NO963255L (no) 1996-10-02

Family

ID=22706020

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963255A NO963255L (no) 1994-02-03 1996-08-02 Sykliske neurokinin-A antagonister

Country Status (19)

Country Link
US (1) US5521156A (es)
EP (1) EP0741743B1 (es)
JP (2) JPH09511490A (es)
KR (3) KR100380872B1 (es)
CN (1) CN1139931A (es)
AT (1) ATE172205T1 (es)
AU (1) AU691246B2 (es)
CA (1) CA2182486C (es)
DE (1) DE69505351T2 (es)
DK (1) DK0741743T3 (es)
ES (1) ES2123234T3 (es)
FI (1) FI963074L (es)
HU (1) HUT74383A (es)
IL (1) IL112489A0 (es)
MX (1) MX9603194A (es)
NO (1) NO963255L (es)
NZ (1) NZ279595A (es)
WO (1) WO1995021187A1 (es)
ZA (1) ZA95710B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830863A (en) * 1988-06-20 1998-11-03 Merrell Pharmaceuticals Inc. Neurokinin A antagonists
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US5521156A (en) * 1994-02-03 1996-05-28 Merrell Pharmaceuticals Inc. Cyclic neurokinin A antagonists
US5879659A (en) * 1996-03-13 1999-03-09 Dupont Pharmaceuticals Company Ternary radiopharmaceutical complexes
MX9709494A (es) * 1996-12-04 1998-07-31 Pfizer Compuestos peptidicos ciclicos, procedimiento para su produccion, composiciones que los contienen y uso de los mismos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102877A (en) * 1976-07-28 1978-07-25 Merck & Co., Inc. Cyclization of peptides
US4659691A (en) * 1985-02-08 1987-04-21 Merck & Co., Inc. Novel cyclic Hexapeptide LHRH antagonists
IT1233696B (it) * 1989-05-29 1992-04-14 Menarini Farma Ind Peptidi di sintesi antagonisti della neurochinina a. loro sali e relativi procedimenti di fabbricazione
IT1241761B (it) * 1990-08-03 1994-02-01 Menarini Farma Ind Peptidi di sintesi antagonisti della neurochinina a, loro sali e relativi procedimenti di fabbricazione
ATE155486T1 (de) * 1991-08-13 1997-08-15 Takeda Chemical Industries Ltd Zyklische peptide und ihre verwendung
US5521156A (en) * 1994-02-03 1996-05-28 Merrell Pharmaceuticals Inc. Cyclic neurokinin A antagonists

Also Published As

Publication number Publication date
JP2005089471A (ja) 2005-04-07
WO1995021187A1 (en) 1995-08-10
JPH09511490A (ja) 1997-11-18
MX9603194A (es) 1997-05-31
KR100380873B1 (ko) 2003-04-18
EP0741743A1 (en) 1996-11-13
IL112489A0 (en) 1995-03-30
ZA95710B (en) 1995-10-16
KR100380872B1 (ko) 2003-04-18
NZ279595A (en) 1997-12-19
EP0741743B1 (en) 1998-10-14
DE69505351T2 (de) 1999-06-02
CA2182486C (en) 2002-10-08
ATE172205T1 (de) 1998-10-15
FI963074A7 (fi) 1996-08-02
CA2182486A1 (en) 1995-08-10
HU9602157D0 (en) 1996-09-30
NO963255D0 (no) 1996-08-02
DK0741743T3 (da) 1999-06-23
AU1677195A (en) 1995-08-21
DE69505351D1 (de) 1998-11-19
CN1139931A (zh) 1997-01-08
FI963074A0 (fi) 1996-08-02
AU691246B2 (en) 1998-05-14
ES2123234T3 (es) 1999-01-01
FI963074L (fi) 1996-08-02
KR100378726B1 (ko) 2003-10-04
HUT74383A (en) 1996-12-30
US5521156A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
LV12350A (lv) Heptapeptida oksitocina analogi
FI76558C (fi) Foerfarande foer framstaellning av en vid blodtrycksjukdom anvaendbar inhibition foer angiotensinomvandlande enzym.
HUP9901209A2 (hu) Opioid analóg peptid vegyületek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
AU4831899A (en) 5-HT1F agonists
KR910011891A (ko) 펩티드 화합물, 이의 제조방법 및 이를 함유하는 약학적 조성물
EA200400815A1 (ru) Контролируемый синтез зипразидона и его композиции
CS291391A3 (en) Dipeptide l-proline-l-ergininaldehyde derivative and a pharmaceutical comprising thereof
ATE284853T1 (de) Ureido-thiobuttersäurederivate als ppar-agonisten
ATE245435T1 (de) Totalsynthese des amino hip analogen von didemnin a
EP0982988A4 (en) IN KEY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF "TIGHT JUNCTIONS" IN MAMMALS
CA2060034A1 (en) Tumour growth-inhibiting somatostatin analogues, pharmaceutical compositions containing them and process for preparing same
FI824419A0 (fi) Cykliska oktapeptider och farmaceutiska preparat daerav, samt foerfarande foer deras framstaellning deras anvaendning
EP0296581A3 (en) Amino acid 1,2-diketo derivatives as renin inhibitors
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
NO963255L (no) Sykliske neurokinin-A antagonister
AU4611589A (en) Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof.
ES2186730T3 (es) Compuestos oligoppeptidicos que contienen un aminoacido d-2-alquiltriptofano y que son capaces de liberar hormona de crecimiento.
DK0871612T3 (da) Kondenserede isoindoloner som proteinkinase C-inhibitorer
BR9712144A (pt) Novos antagonistas de nmda (d- aspartato de n-metila).
EA200100918A1 (ru) Агонисты 5-ht1f рецептора
DE69834929D1 (de) Verwendung eines organspezifischen ernährungmittels
NO20004613L (no) FremgangsmÕte for fremstilling av et tetrapeptid
DK0701551T3 (da) 3-(Indol-3-yl)propensyrederivater som NMDA-antagonister
AU1730800A (en) A method for the preparation of n-neohexyl-alpha-aspartyl-l-phenylalanine methylester from imidazolidin-4-one intermediates
DE58908128D1 (de) Verbindungen zur Einführung einer SH-Gruppe in Tyrosin.